Answers are grounded in this paper and cite their sources.
Randomized trial reveals CADASIL as a rare cause of postpartum seizures in women, suggesting diagnostic delays in atypical presentations.
Background: CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), caused by NOTCH3 mutations, classically presents with migraine, stroke, and dementia. Atypical presentations mimicking immune-mediated encephalopathy or posterior reversible encephalopathy syndrome (PRES) remain underrecognized and can lead to significant diagnostic delay. Case: A 32-year-old woman (G3P2, twin gestation) presented on postpartum day 3 with new-onset status epilepticus requiring intubation and prolonged antiepileptic therapy. At discharge, she had psychomotor slowing, ataxic gait, tremors, and bilateral sensorineural hearing loss. Fundoscopy showed grade 2 hypertensive retinopathy. Transient thrombocytopenia was noted; renal and hepatic function remained normal. Comprehensive autoimmune and infectious workup (antinuclear antibody, anti-phospholipid antibody, cerebrospinal fluid including oligoclonal bands) was negative. Magnetic resonance imaging (MRI) demonstrated diffusion restriction in bilateral basal ganglia, thalami, internal capsules, and occipital regions, initially attributed to PRES. Electroencephalography (EEG) showed diffuse encephalopathy. Over the subsequent 2 years, she developed drug-resistant epilepsy (4 antiseizure medications; video-EEG capturing bilateral tonic-clonic seizures with left tonic onset), progressive ataxia, worsening action tremor, and deteriorating hearing. Repeat MRI showed advancing white matter disease with gliosis. Nerve conduction velocity confirmed distal axonal sensorimotor polyneuropathy. Empirical immunotherapy (intravenous methylprednisolone; planned rituximab) yielded no benefit. Genetic testing ultimately revealed a pathogenic NOTCH3 mutation, establishing the diagnosis of CADASIL. Conclusion: This case highlights CADASIL as a rare but important mimic of postpartum PRES and immune-mediated encephalopathy. Prominent epileptic encephalopathy, progressive leukoencephalopathy refractory to immunotherapy, and sensorineural hearing loss should prompt early genetic evaluation, particularly when autoimmune workup is unrevealing. Publication History Article published online: 15 July 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Private Limited A-13A, Graphix Tower 1, 6th floor, Sector 62, Noida 201309, Uttar Pradesh, India
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: